Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Need ways to make money to cover bills? Check out various options that can help you earn extra cash and manage your expenses.
15,191 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
VanEck BDC Income ETF faces pressure from rate cuts eating into floating-rate loan income. Distributions declined in ...
With burnout on the rise in early 2026, workers seek structured ways to reduce load without leaving their jobs. Inves...
XRP is trading in a tight range as Binance derivatives data shows extreme negative funding. Traders fear a potential ...
February data show a modest uptick in existing-home sales, but the market faces spring headwinds from affordability p...
A leading economist warns that renewed hostilities with Iran could trigger a butterfly effect in global markets, keep...
Gas prices are edging higher in March 2026 as geopolitical tensions lift crude costs. A new chart breaks down the pri...
Southern Company is near Dividend Aristocrat territory after two decades of increases, yet a massive five-year capita...
A trio of high-yield names—PNNT, GLAD, and KRP—show divergent payout reliability even as yields approach double digit...
Insiders are loading up Arbor Realty Trust while bears keep a large short position. The clash over who’s right Arbor ...
Insider moves can ripple through biotech stocks. This piece breaks down recent tarsus pharma stock insider activity, ...
A joint Accenture-Wharton study finds AI agents can scale thinking, but human governance struggles to keep pace, crea...